Analyst, US Trade Compliance jobs in United States
cer-icon
Apply on Employer Site
company-logo

Abbott · 12 hours ago

Analyst, US Trade Compliance

Abbott is a global healthcare leader that helps people live more fully at all stages of life. The Analyst, US Trade Compliance will conduct audits of Abbott’s U.S. import/export operations to ensure compliance with applicable U.S. customs regulations.

BiotechnologyEmergency MedicineGeneticsHealth CareHealth DiagnosticsManufacturingMedicalMedical DeviceNutritionPharmaceutical

Responsibilities

Perform transactional testing/audits as a member of the US trade compliance audit team
Perform periodic spot checks to assess the timeliness and effectiveness of the site/division post-entry/post-export review processes
Conduct quarterly risk-targeting analysis
Provide analytical support for disclosures and other reporting requirements
Monitor site/division compliance improvement plans to ensure timely implementation and close-out

Qualification

US customs regulationsHTSUS tariff classificationFinance/Accounting experienceAudit experienceMultitaskingAttention to detailOrganizational skills

Required

Bachelor's degree required (finance, supply chain, or other relevant area)
Minimum of 2-3 years experience (Finance/Accounting, Audit, Compliance, Materials Management, or other related field)
Must be able to work independently, perform under pressure, multitask with tight deadlines, and adapt to a fast-paced environment
The incumbent must be a highly organized professional with a strong attention to detail

Preferred

Experience in HTSUS tariff classification strongly preferred

Benefits

Free medical coverage in our Health Investment Plan (HIP) PPO medical plan
An excellent retirement savings plan with a high employer contribution
Tuition reimbursement
The Freedom 2 Save student debt program
FreeU education benefit - an affordable and convenient path to getting a bachelor’s degree

Company

Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.

Funding

Current Stage
Public Company
Total Funding
$6.79M
2011-03-15Post Ipo Debt· $0.1M
2009-03-16Post Ipo Debt· $6.69M
1980-12-12IPO

Leadership Team

leader-logo
Robert Ford
President & Chief Executive Officer
linkedin
leader-logo
Mike Peterson
Senior Vice President
linkedin
Company data provided by crunchbase